Oseltamivir vs Tofacitinib

## Oseltamivir vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Oseltamivir** and **Tofacitinib**.

## Mechanism of Action

**Oseltamivir**: Neuraminidase inhibitor preventing viral release from host cells.

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Oseltamivir — 6-10 hours; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Oseltamivir — C16H28N2O4; Tofacitinib — C16H20N6O.

**Molecular Weight**: Oseltamivir — 312.4050 g/mol; Tofacitinib — 312.3700 g/mol.

**Type**: Oseltamivir — Small molecule; Tofacitinib — Small molecule.